Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri Lanka | Zendy

Deepa Gamage | Zendy; Ondrej Mach | Zendy; Samitha Ginige | Zendy; William C. Weldon | Zendy; M. Steven Oberste | Zendy; Visalakshi Jeyaseelan | Zendy; Roland W. Sutter | Zendy

Open Access

Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri Lanka

Author(s) -

Deepa Gamage,

Ondrej Mach,

Samitha Ginige,

William C. Weldon,

M. Steven Oberste,

Visalakshi Jeyaseelan,

Roland W. Sutter

Publication year - 2019

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jiz026

Subject(s) - inactivated poliovirus vaccine , seroprevalence , poliovirus , medicine , virology , immunization , antibody , titer , poliomyelitis , neutralizing antibody , antibody titer , immunology , virus , serology

In July 2016, Sri Lanka replaced 1 intramuscular dose of inactivated poliovirus vaccine (IPV) with 2 doses of intradermal fractional-dose IPV (fIPV) in its routine immunization schedule. We carried out a survey of seroprevalence of antipolio antibodies in children who received 2 fIPV doses and compared it with those who received 1 full IPV dose.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research